- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03880175
Direct and Spillover Impacts of a Community-Level HIV/AIDS Program (FCC)
Direct and Spillover Impacts of a Community-Level HIV/AIDS Program: Evidence From a Randomized Controlled Trial in Mozambique
The HIV/AIDS crisis in Sub-Saharan Africa has left millions of children orphaned. These children, who are potentially infected with HIV themselves, are highly vulnerable and face some serious risks to their health and overall well-being.
A variety of health and economic interventions to help orphans and vulnerable children (OVCs) (and the households in which they live) are being carried out in Mozambique by World Education Inc./Bantwana (WEI/B), funded by USAID. The program is known in Portuguese as Força à Comunidade e Crianças or FCC (in English, "Strengthening Family and Communities").
This study will collect survey and administrative data to assess the impact of the FCC program on OVCs and the households in which they live. A baseline survey was administered to define a sample of households and individuals to follow over time through the upcoming follow-up survey and to measure baseline household characteristics.
Follow-up data collection will begin in March 2019. It has several components:
- Household survey The follow-up survey will provide measurements of the rich set of intermediate and final outcomes for the estimation of treatment effects of the FCC program.
Data collection on HIV testing and school attendance This study will supplement survey-reported HIV testing rates with an objective, administrative measure of HIV testing at health clinics. At the time of the follow-up survey, the survey team will recommend that eligible individuals in the household be tested for HIV at a specified local health clinic. To allow tracking of those who follow through with testing, consenting individuals will be given coupons redeemable for a small financial incentive once they have completed an HIV test.
In addition to self-reported data on school participation by children, this study will also measure school participation directly. Both school enrollment (presence in school registration records) and school attendance (physical presence of children in school during unannounced school visits by research staff) will be measured. Project staff will visit schools in study communities to check attendance rates of specific school-aged children who were listed in the baseline survey in their community.
- Informational treatments aimed at raising HIV testing rates To allow insight into the mechanisms through which the FCC program has its effects, this study will provide additional simple treatments in the context of the follow-up survey to explore possible FCC mechanisms: stigma reduction, HIV/AIDS information, and HIV treatment (antiretroviral therapy, or ART) information.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
- Comportamental: FCC (Força à Comunidade e Crianças) program- direct beneficiary
- Comportamental: Anti Stigma Information
- Comportamental: HIV/AIDS Information
- Comportamental: ART Information
- Comportamental: HIV/AIDS and ART Information Combined
- Comportamental: High coupon value
- Comportamental: FCC (Força à Comunidade e Crianças) program- non-direct beneficiary
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Sofala
-
Beira, Sofala, Moçambique
- Lessitala Consultoria e Servicos
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Households that lives in one of the eligible communities.
Exclusion Criteria:
- Households that are not in the eligible communities will not be included in the survey sample.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição fatorial
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: FCC DEB and Anti-stigma
|
Households are directly linked to the FCC implementing organization
Adults in the households are provided anti-stigma information
|
|
Experimental: FCC DEB and HIV info
|
Households are directly linked to the FCC implementing organization
The households receive information about HIV infection and AIDS
|
|
Experimental: FCC DEB and ART info
|
Households are directly linked to the FCC implementing organization
The households receive information about antiretroviral therapy.
|
|
Experimental: FCC DEB and HIV-ART info
|
Households are directly linked to the FCC implementing organization
The households receive both information about HIV/AIDS and information about antiretroviral therapy.
|
|
Experimental: FCC DEB and high coupon value
|
Households are directly linked to the FCC implementing organization
The HIV testing coupons distributed to households in this group have higher values.
|
|
Experimental: FCC DEB and no info
|
Households are directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and Anti-stigma
|
Adults in the households are provided anti-stigma information
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and HIV info
|
The households receive information about HIV infection and AIDS
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and ART info
|
The households receive information about antiretroviral therapy.
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and HIV-ART info
|
The households receive both information about HIV/AIDS and information about antiretroviral therapy.
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and high coupon value
|
The HIV testing coupons distributed to households in this group have higher values.
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC non-DEB and no info
|
Households live in FCC implementing communities but are not directly linked to the FCC implementing organization
|
|
Experimental: FCC control and Anti-stigma
|
Adults in the households are provided anti-stigma information
|
|
Experimental: FCC control and HIV info
|
The households receive information about HIV infection and AIDS
|
|
Experimental: FCC control and ART info
|
The households receive information about antiretroviral therapy.
|
|
Experimental: FCC control and HIV-ART info
|
The households receive both information about HIV/AIDS and information about antiretroviral therapy.
|
|
Experimental: FCC control and High coupon value
|
The HIV testing coupons distributed to households in this group have higher values.
|
|
Sem intervenção: FCC control and no info
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Indicator for HIV testing coupon redemption at the household level
Prazo: 14 days following the date coupons are distributed to a household.
|
This is a household-level binary variable. It takes value 1 if at least one of a household's coupons is redeemed, and 0 otherwise. The researcher will distribute coupons at the household survey. A subject is eligible for a coupon if s/he is not reported HIV+ and has not had an HIV test within 3 months before the visit. A coupon for an adult will be distributed to themselves. A coupon for a child (age <18) will be distributed to their primary guardian. Each coupon has a value of 50Mts (0.83 USD) and is valid for 14 days. To redeem a coupon, a coupon holder must show up in the designated clinic and provide proof of testing dated within the coupon-validity window. There is a unique barcode on each coupon to allow the researcher to track the use of each coupon. A coupon will be scanned when distributed and redeemed to link to a subject. The analysis sample for this outcome of interest is all households that have received at least one coupon from the researcher. |
14 days following the date coupons are distributed to a household.
|
|
Indicator for school attendance at the child-level
Prazo: The time when the research team is conducting the school visit, which lasts 4 to 8 hours in each school
|
This is an individual-level binary variable. It takes value 1 if a school-aged child (6 -17 years of age) is physically present at school on the date the research staff conducts an unannounced school visit; it takes the value of 0 otherwise. The research team will make an unannounced school visit to check the attendance of all school-aged children in the study sample. All school-aged children will be checked regardless of his or her guardian-reported school attendance status. The study team will visit all public primary and secondary schools located in the study community. All unannounced visits will happen on regular school days. Each child will be checked in all neighboring schools. Each child will only be checked once in one school. The analysis sample of this outcome of interest is all school-aged children living in the study households. |
The time when the research team is conducting the school visit, which lasts 4 to 8 hours in each school
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Infecções por vírus de RNA
- Doenças Virais
- Infecções
- Infecções transmitidas pelo sangue
- Doenças Transmissíveis
- Doenças Sexualmente Transmissíveis, Virais
- Doenças Sexualmente Transmissíveis
- Infecções por Lentivírus
- Infecções por Retroviridae
- Síndromes de Deficiência Imunológica
- Doenças do sistema imunológico
- Doenças de Vírus Lento
- Infecções por HIV
- Síndrome da Imunodeficiência Adquirida
Outros números de identificação do estudo
- HUM00113011
- AID-OAA-L-12-00001 (Número de outro subsídio/financiamento: USAID)
- AID-OAA-LA-16-0004 (Número de outro subsídio/financiamento: USAID)
- AID391A1500006 (Número de outro subsídio/financiamento: USAID)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .